Target Healthcare REIT – executive interview
13/08/2026
In this interview, Kenneth MacKenzie, CEO of Target Fund Managers, talks about the latest quarterly update from Target Healthcare REIT and the outlook. The three months to 30 June 2026 (Q426) was another strong period for financial performance and rounded off a very successful FY26 year. Q4 showed the familiar pattern of inflation-linked rental growth and active asset management consistently driving both earnings and capital growth, with further progress on the redeployment of the proceeds of last year’s sale of nine homes. FY26 accounting total return was c 12%, taking the three-year return to c 34%, and the shares have performed well. Our update note can be found here. Kenneth discusses both the short-term financial, operational and strategic progress and the longer-term structural tailwinds for the sector that underpin the company’s steady and consistent performance.
Target Healthcare REIT — Strong FY26 underpins strong share price
11/08/2026
Target Healthcare REIT generated a Q426 accounting total return of 2.5%, taking the FY26 total to 11.6%. Even more impressive, this has been generated with a relatively low level of gearing (end-Q426 net LTV of 16.1%) as the company makes progress with redeploying the proceeds of the late 2025 portfolio sale. We expect organic, inflation-indexed rental growth and accretive capital recycling to drive consistent earnings and growth, uncorrelated with, and independent of, heightened economic uncertainties.
Target Healthcare REIT — Q326 progress ahead of accretive deployment
11/05/2026
Target Healthcare REIT’s Q326 update shows continuing steady operational and financial progress, driven by the company’s active asset management and highly supportive sector fundamentals. We expect organic, inflation-indexed rental growth and accretive capital recycling to drive consistent earnings and growth, uncorrelated with, and independent of, heightened economic uncertainties. The company expects to have materially deployed the proceeds of its recent portfolio sale by the end of the current financial year and has a strong pipeline of similarly attractive opportunities.